John Bluth | executive |
Jon Stonehouse | executive |
Charles Gayer | executive |
Anthony Doyle | executive |
Tazeen Ahmad | analyst |
Stacy Ku | analyst |
Liisa Bayko | analyst |
Serge Belanger | analyst |
Good morning, and welcome to the BioCryst Pharmaceuticals' Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note, this event is being recorded.
I would like now to turn the conference over to John Bluth at BioCryst.